Page last updated: 2024-08-22

platinum and tivozanib

platinum has been researched along with tivozanib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adorno-Cruz, V; Berry, E; Cowan, M; Kocherginsky, M; Lurain, JR; Matei, D; Nelson, V; Neubauer, NL; O'Shea, KL; Pineda, MJ; Shahabi, S; Swetzig, WM; Taiym, D	1

Trials

1 trial(s) available for platinum and tivozanib

Article	Year
Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial. Gynecologic oncology, 2021, Volume: 163, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Phenylurea Compounds; Platinum; Quinolines	2021

Article

Year

Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial.

Gynecologic oncology, 2021, Volume: 163, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Phenylurea Compounds; Platinum; Quinolines

2021